205 related articles for article (PubMed ID: 18727487)
21. High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis.
Mahé E; Bodemer C; Descamps V; Mahé I; Crickx B; De Prost Y; Favre M
Br J Dermatol; 2003 Oct; 149(4):819-25. PubMed ID: 14616375
[TBL] [Abstract][Full Text] [Related]
22. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
Yoshida R; Kato T; Kawase M; Honda M; Mitsuishi T
BMC Dermatol; 2014 Jul; 14():12. PubMed ID: 25048734
[TBL] [Abstract][Full Text] [Related]
23. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
24. Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology.
O'Blenes C; Pasternak S; Issekutz A; Gillis J; Chowdhury D; Finlayson L
Pediatr Dermatol; 2015; 32(1):118-21. PubMed ID: 23534907
[TBL] [Abstract][Full Text] [Related]
25. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.
Ramoz N; Rueda LA; Bouadjar B; Montoya LS; Orth G; Favre M
Nat Genet; 2002 Dec; 32(4):579-81. PubMed ID: 12426567
[TBL] [Abstract][Full Text] [Related]
26. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses.
Bouwes Bavinck JN; Stark S; Petridis AK; Marugg ME; Ter Schegget J; Westendorp RG; Fuchs PG; Vermeer BJ; Pfister H
Br J Dermatol; 2000 Jan; 142(1):103-9. PubMed ID: 10651702
[TBL] [Abstract][Full Text] [Related]
27. Epidermodysplasia verruciformis and susceptibility to HPV.
Patel T; Morrison LK; Rady P; Tyring S
Dis Markers; 2010; 29(3-4):199-206. PubMed ID: 21178278
[TBL] [Abstract][Full Text] [Related]
28. Acquired epidermodysplasia verruciformis.
Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
[TBL] [Abstract][Full Text] [Related]
29. Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls.
Michael KM; Waterboer T; Pfister H; Gariglio M; Majewski S; Favre M; Pawlita M
J Invest Dermatol; 2010 Mar; 130(3):841-8. PubMed ID: 19924140
[TBL] [Abstract][Full Text] [Related]
30. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.
Crequer A; Picard C; Patin E; D'Amico A; Abhyankar A; Munzer M; Debré M; Zhang SY; de Saint-Basile G; Fischer A; Abel L; Orth G; Casanova JL; Jouanguy E
PLoS One; 2012; 7(8):e44010. PubMed ID: 22952854
[TBL] [Abstract][Full Text] [Related]
31. Homozygosity for the c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz.
Arnold AW; Burger B; Kump E; Rufle A; Tyring SK; Kempf W; Häusermann P; Itin PH
Dermatology; 2011 Feb; 222(1):81-6. PubMed ID: 21196704
[TBL] [Abstract][Full Text] [Related]
32. Multiple flat-topped scaly violaceous papules.
Girijala RL; Nyinawinyange D; Parekh PK; Grimwood RE
Dermatol Online J; 2019 Mar; 25(3):. PubMed ID: 30982308
[TBL] [Abstract][Full Text] [Related]
33. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance.
Majewski S; Jablonska S
Am J Med Sci; 1992 Sep; 304(3):174-9. PubMed ID: 1335684
[TBL] [Abstract][Full Text] [Related]
34. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.
Lazarczyk M; Cassonnet P; Pons C; Jacob Y; Favre M
Microbiol Mol Biol Rev; 2009 Jun; 73(2):348-70. PubMed ID: 19487731
[TBL] [Abstract][Full Text] [Related]
35. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in cutaneous HPV infection.
Shimizu A; Yamaguchi R; Kuriyama Y
J Dermatol; 2023 Mar; 50(3):290-298. PubMed ID: 36601717
[TBL] [Abstract][Full Text] [Related]
37. TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.
Esenboga S; Cagdas D; Alkanat NE; Güler Tezel G; Ersoy Evans S; Boztug K; Tezcan I
J Cosmet Dermatol; 2022 May; 21(5):2263-2267. PubMed ID: 34416085
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis.
Tate G; Suzuki T; Kishimoto K; Mitsuya T
J Hum Genet; 2004; 49(4):223-225. PubMed ID: 15042430
[TBL] [Abstract][Full Text] [Related]
39. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
[TBL] [Abstract][Full Text] [Related]
40. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
Connolly K; Manders P; Earls P; Epstein RJ
Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
